Canny save today. |
No respite here. Painful. The recent rise must have been on hope of a 6k farm in. I think that interest has just disappeared. Must have bn the inflated price the new TimeLord was asking. But let s hope not. We live in hope. |
Fieldhouse- darn missed a trick there you officianado! 2 hearts beat as one - aka The Song of Gallifrei! Get it on i-tunes now. Takes six months to download though, longer than the Mahaberata. Watch a 4 HR snippet the other day. My word - a snippet! Cultural awareness is good. I'm heading up Reform Maga UKs diversity training, now that their 'great' leader is in the lovely Belmarsh. |
Not exterminated ! Just a new incarnation! |
 POLX Polarean Imaging will break out above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.
Putting this UK recovery play potential on radars.
1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.
APPROX 13P SHARE PRICE EQUIVALENT FOR POLX
2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M
APPROX 48P SHARE PRICE EQUIVALENT FOR POLX
3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.
APPROX 22P SHARE PRICE EQUIVALENT FOR POLX
4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout
POLX easy buyout target imv. DYOR, not advice. |
Hi Chesh ... show me the licensing deal for 6k and I might, just might, make me cheer up. Not only that, but the deal has to support the super bloated mkt cap and share price I.d be happy with £8m net profit. Without it this share price is unsustainable. Just saying. Crispr gonna eat ya. |
Ama just predicting another drop? |
....back here soon ama?
lol, never been away. Dip in here every now and again. FUDsters need to up their game though and find some new material as no use repeating old stuff. |
Whitey in denial, about a lot of things me thinks.How.s your gambling doing numbnuts? Bought back in for a punt have you,? The usual will soon be here. Raj,Chesh etc |
Rajraj b "Why have they bothered to collaborate with Tempus then?"
There is no collaboration with Tempus. Its just a joint statement by both parties paid for by Avacta to sucker in retail investors. What happened to the collaboration with William Tap of Memorial Sloan Kettering Cancer Center first announced in RNS 06/04/2023.
In fact way before April last year they announced a collaboration with Memorial Sloan Kettering Cancer Center back in November 2016.
RNS 02/11/2016 - "The collaboration will be led by Renier J. Brentjens, MD, PhD, Director of Cellular Oncology at Memorial Sloan Kettering Cancer Center in New York."
All the collaborations are just announcements to give the impression of a functioning UK biotech company which they are not. |
Well, Friday nearly slipped away, another day another dollar. Have a good un. Ps all the traders have slipped away again after a nice little run of appearances banter. Most will have lost a few more quid. News inbound soon. Let's see how keen they are on progressing AV6k, but at what price?
America going keto - try it. Very poor data for long term usage, v hard to maintain. |
You.ll all be following the carnivore diet now Trump has been installed. |
POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.
Putting this UK recovery play potential on radars.
1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.
APPROX 13P SHARE PRICE EQUIVALENT FOR POLX
2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M
APPROX 48P SHARE PRICE EQUIVALENT FOR POLX
3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.
APPROX 22P SHARE PRICE EQUIVALENT FOR POLX
4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout
POLX easy buyout target imv. DYOR, not advice. |
Dodgy times now for anything pharma wise, watch this space jfk, Jr we seen our very own. Gov manipulation over lfts, I don't think we've seen anything yet, iffy times ahead, and that's no conspiracy either |
Clue to the share price rise? Strong rise or just helping convi Boyz out? Rinse repeat. Where y'all gone? Your masters have told I to plague some other board |
Boom! 😁 |
Nut kicker again today. How y'all doing you dim Trump fans?! |
Some bizarre posts today for sure. I.m not going to bite at the obvious immaturity which abounds. All that matters to me, is why did Smith leave? It.s the great mammoth in the bldy room. We know that he is was a master of delay, subterfuge,economy with the truth, timing etc so just what has he been up to? Any new board appointments for him elsewhere. I hope he hasn't gone for health reasons bcos that would be cruel. Poor Hoy, a great, great cyclist, model athlete, a real gent. He.ll be sorely missed. Having a bubble while I type. Poor guy. Ps if you.re here, got youth on your side, do all you can to stay healthy. All the money in the world wont help much if you.re in pain, can't get out, or facing the end. Trust me on this - others will verify. |
"It cannot target a warhead only to be released when it comes into contact with FAP. If so how does it do it at the biochemical level."By enzymatic cleavage. It's how enzymes work. |
I watched a very moving interview with Sir Chris Hoy on BBC breakfast program.Diagnosed with terminal cancer !
The chemo treatment that was actually making him feel ill !
Good luck Avacta |
Wasteful if you're trying to keep yourself accustomed to the lifestyle you're used to. |
Why have they bothered to collaborate with Tempus then? |
Are you a rational human being or a bot? |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
